SIC
RGNX icon

SJS Investment Consulting’s Regenxbio RGNX Stock Holding History

SJS Investment Consulting’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288 Buy
24
+5
+26% +$41 ﹤0.01% 2408
2026
Q1 		$160 Sell
19
-33
-63% -$347 ﹤0.01% 2034
2025
Q4 		$749 Buy
+52
New +$648 ﹤0.01% 1391

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SJS Investment Consulting's RGNX Position: Q2 2026 in Review

SJS Investment Consulting increased its Regenxbio (RGNX) stake by 26% in Q2 2026, buying an estimated $41 and bringing the position to 24 shares worth $288. The position accounts for ﹤0.01% of the portfolio, ranked #2408.

SJS Investment Consulting first reported a position in RGNX in Q4 2025 and has held it in 3 quarters since. The position peaked at $749 in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • SJS Investment Consulting held 24 shares of Regenxbio worth $288 as of Q2 2026.
  • SJS Investment Consulting bought 5 Regenxbio shares in Q2 2026, an estimated $41.
  • Regenxbio made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2408 holding.
  • SJS Investment Consulting first reported a position in Regenxbio in Q4 2025 and has held it in 3 quarters since.
  • SJS Investment Consulting's Regenxbio position peaked at $749 in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.